May 10, 2022

HSP-Led GAIHN-HAI Network Begins COVID-19 Variant Surveillance in Indonesia

HSP and Indonesian partners at Dr. Soetomo Hospital and the Institute of Tropical Diseases, Universitas Airlangga (ITD) have started COVID-19 variant surveillance in health care workers and hospitalized patients. As a result, these partners will be able to identify and characterize existing and emerging SARS-CoV-2 variants and support national and global response to the pandemic. This effort is part of HSP’s support for the U.S. Centers for Disease Control and Prevention (CDC) Global Action in Healthcare Network - Healthcare-associated Infection Module (GAIHN-HAI). GAIHN-HAI focuses on developing networks of healthcare facilities dedicated to improving detection and response for healthcare-associated infections (HAIs), implementing evidence-based strategies for infection prevention and control (IPC) in healthcare settings, and ultimately delivering safer healthcare. Over the last six months, CDC and HSP teams have been working with long-time and new partners in Indonesia to bring together a network of hospitals and laboratories to build capacity to detect existing and emerging COVID-19 variants in healthcare workers and hospitalized patients. In the next month, more Indonesian network sites will be joining Dr. Soetomo Hospital and the Institute of Tropical Diseases, Universitas Airlangga. In addition to supporting the GAIHN network, these institutions will also be contributing to the Indonesian Ministry of Health’s response to the pandemic. HSP is also establishing GAIHN-HAI networks in Brazil and the Philippines. *HSP is proud to partner with CDC, as supported through Cooperative Agreement CK-21-2104. CDC is an agency within the Department of Health and Human Services (HHS). The contents of this post do not necessarily represent the policies of CDC or HHS and should not be considered an endorsement by the U.S. Federal Government.